Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

NCT06821880 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT06821880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06821880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
Lead sponsor
Medical University Innsbruck
Phase
Observational
Overall status
Recruiting
Start date
February 3, 2025
Completion date
July 31, 2026
Enrollment
120 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukaemia (cll), multiple myeloma (mm), secondary immunodeficiency (sid)